Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.
about
A new in vivo screening paradigm to accelerate antimalarial drug discoveryQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainChloroquine is grossly under dosed in young children with malaria: implications for drug resistanceAutophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discoveryInterspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesSynergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species.Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.Chloroquine neither eliminates liver stage parasites nor delays their development in a murine Chemoprophylaxis Vaccination model.Validation of a chloroquine-induced cell death mechanism for clinical use against malariaMechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria.Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptomsPharmacokinetics, metabolism, and in vivo efficacy of the antimalarial natural product bromophycolide AKnow your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.New insight-guided approaches to detect, cure, prevent and eliminate malaria.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.To kill or not to kill, that is the question: cytocidal antimalarial drug resistance.Development and validation of an HILIC-MS/MS method by one-step precipitation for chloroquine in miniature pig plasma.A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase Model
P2860
Q28534314-277FCDD1-0B4E-48B5-AFCC-03CE7FA90346Q28538830-EA97B1D0-681A-40DF-837B-C73D098D9EFEQ28539103-4C0567E4-DBDB-4431-8EEB-D195839A2ECCQ30584653-752C1BC3-FB81-4F61-9FA6-034A3895B3F2Q33757336-A4776500-6A77-454C-A650-95A3AB60ACC6Q34299078-3625E47F-71C3-4CC8-8E5C-A12C140AE672Q34537580-B7D795C0-7063-48A2-9163-3D6139BFB657Q34922167-A469EF12-4C86-4C08-A654-C3E1617A0A90Q34953705-34D917A4-9BAA-41BD-B1D7-12114AAAD310Q35105804-5249A8B9-C4E8-43AF-AC31-8A1DA055BB68Q35105913-58E261CE-D236-4DFD-86DC-5D39597E8732Q35336088-37A9FF2D-79DD-412B-8301-20323842CAD4Q36179646-CC65C222-0DF3-496E-87AE-592D134DB89DQ36505504-AA3848F3-ECD9-4C1C-B13B-F5578A6B9600Q37108173-678B12E7-A3D9-48EB-88A2-D6D308CF9CEFQ37225238-D114BB1A-91DA-4C9F-AE11-BAA137C7FE65Q37244996-AB6385FF-6D49-4FC8-B514-97A5A1F7EBE8Q37979631-528EFF83-BDA9-45C5-B9B6-960E0FE131A7Q38260909-A2FCADB4-A0C8-4CA9-BD82-A55249B1BF06Q38360827-490286F8-14D7-4D13-8D49-1A94E0AC07FEQ38670231-D537EBAA-438A-4FCE-BE4E-9D2C11A47B4AQ38864034-A5883269-32A0-4AF0-8139-129B066B7B37Q42645380-2EDEA349-9171-41A9-8BF6-2122CEC6ED5BQ52680719-712BBA8B-8973-4D3A-838C-74069F5B5391Q56339840-E1FF2C0D-802E-42D8-A02F-DC1B7FFC67B9
P2860
Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@ast
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@en
type
label
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@ast
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@en
prefLabel
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@ast
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@en
P2093
P2860
P356
P1476
Pharmacokinetics, pharmacodyna ...... ine in a murine malaria model.
@en
P2093
Jeffrey D Jago
Jillian R Stoney
Kenneth F Ilett
Madhu Page-Sharp
P2860
P304
P356
10.1128/AAC.00067-11
P407
P577
2011-06-06T00:00:00Z